AI Verdict
NBRWF has stronger fundamentals based on our AI analysis.
NBY vs NBRWF Fundamental Comparison
| Metric | NBY | NBRWF |
|---|---|---|
| Revenue | $521,000.0 | $3.2B |
| Net Income | $-22.1M | $286.6M |
| Net Margin | -4,249.7% | 9.0% |
| ROE | N/A | 48.5% |
| ROA | -245.1% | 6.0% |
| Current Ratio | 7.60x | 1.56x |
| Debt/Equity | N/A | 3.58x |
| EPS | $0.76 | $17.39 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
NBY vs NBRWF: Frequently Asked Questions
Is NBY or NBRWF a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), NBRWF has stronger fundamentals. NBY is rated STRONG SELL (95% confidence) while NBRWF is rated BUY (70% confidence). This is not investment advice.
How does NBY compare to NBRWF fundamentally?
NovaBay Pharmaceuticals, Inc. has ROE of N/A vs NABORS INDUSTRIES LTD's 48.5%. Net margins are -4,249.7% vs 9.0% respectively.
Which stock pays higher dividends, NBY or NBRWF?
NBY has a dividend yield of N/A or no dividend while NBRWF has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in NBY or NBRWF for long term?
For long-term investing, consider that NBY has STRONG SELL rating with 95% confidence, while NBRWF has BUY rating with 70% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about NBY vs NBRWF?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For NBY vs NBRWF, the AI consensus favors NBRWF based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.